Comparative analysis for different vehicle powertrains in terms of energy-saving potential and cost-effectiveness in China

被引:9
|
作者
Liu, Xinglong [1 ,2 ]
Zhao, Fuquan [1 ,2 ]
Hao, Han [1 ,2 ,3 ]
Liu, Zongwei [1 ,2 ]
机构
[1] Tsinghua Univ, State Key Lab Automot Safety & Energy, Beijing 100084, Peoples R China
[2] Tsinghua Univ, Tsinghua Automot Strategy Res Inst, Beijing 100084, Peoples R China
[3] Tsinghua Univ, China Automot Energy Res Ctr, Beijing 100084, Peoples R China
基金
中国国家自然科学基金;
关键词
Vehicle powertrain; Technology evaluation; Energy -saving potential; Direct manufacturing cost; Cost-effectiveness analysis; LIFE-CYCLE ASSESSMENT; REGULATIONS; EFFICIENCY;
D O I
10.1016/j.energy.2023.127564
中图分类号
O414.1 [热力学];
学科分类号
摘要
Technology evaluation of vehicle powertrains is the basis for policymakers and automotive manufacturers to make technical decisions. However, there is a research gap in comparative studies on different powertrain technologies under uniform assumptions (dynamic performance and test-driving cycles) for light-duty vehicles in China. To fill these gaps, this paper proposes an innovative technology evaluation model of the powertrains for the energy-saving cost-effectiveness of powertrains. The results are as follows: as the electrification degree of the powertrain technology increases, its curb mass and direct manufacturing cost increase, while its comprehensive fuel consumption gradually decreases. Changes in curb mass and direct manufacturing cost are the combined effect of powertrain electrification upgrades and engine simplification. ICEV has limited fuel-saving potential and poor cost-effectiveness. HEV can achieve more significant fuel savings with minor cost increases and has the highest cost-effectiveness. PHEV50, REEV180, and BEV400 have high fuel economies, but their cost-effectiveness is poor due to the high cost of the battery system. In the short term, the Chinese government should encourage automotive manufacturers to increase their research and development investment in HEVs to replace ICEVs. In the long term, the government should promote battery technologies to reduce the direct manufacturing cost of NEVs.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Cost-effectiveness analysis of intensive hypertension control in China
    Xie, Xiaolei
    He, Tianhua
    Kang, Jian
    Siscovick, David S.
    Li, Yan
    Pagan, Jose A.
    PREVENTIVE MEDICINE, 2018, 111 : 110 - 114
  • [42] Taking stock of cost-effectiveness analysis of healthcare in China
    Butt, Thomas
    Liu, Gordon G.
    Kim, David D.
    Neumann, Peter J.
    BMJ GLOBAL HEALTH, 2019, 4 (03):
  • [43] COST-EFFECTIVENESS ANALYSIS OF DIALYSIS THERAPY PROGRAM IN CHINA
    Liu, Jing
    Zeng, Xiaoxi
    Ma, Liang
    Fu, Ping
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34
  • [44] Cost-Effectiveness Analysis of China's TCZ Policy
    Ruobing, Liang
    PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON PUBLIC ECONOMICS AND MANAGEMENT ICPEM 2009, VOL 2: ECONOMIC POLICIES, PLANNING AND ASSESSMENT, 2009, : 66 - 69
  • [45] The greenhouse technology in different climate conditions: A comprehensive energy-saving analysis
    Nasrollahi, Hossein
    Ahmadi, Farzin
    Ebadollahi, Mohammad
    Nobar, Shima Najafi
    Amidpour, Majid
    SUSTAINABLE ENERGY TECHNOLOGIES AND ASSESSMENTS, 2021, 47
  • [46] Container farms: Energy modeling considering crop growth and energy-saving potential in different climates
    Song, Ruizhi
    Liu, Dong
    Pan, Yiqun
    Cheng, Yong
    Meng, Chuang
    JOURNAL OF CLEANER PRODUCTION, 2023, 420
  • [47] Universal screening for HCV infection in China: An effectiveness and cost-effectiveness analysis
    Zhou, Hua
    Yan, Mengxia
    Che, Datian
    Wu, Bin
    JHEP REPORTS, 2024, 6 (04)
  • [48] Cost-effectiveness analysis of different hypertension management strategies
    Arrigo F. G. Cicero
    Federica Fogacci
    Claudio Borghi
    Internal and Emergency Medicine, 2020, 15 : 181 - 182
  • [49] Cost-effectiveness analysis of different hypertension management strategies
    Cicero, Arrigo F. G.
    Fogacci, Federica
    Borghi, Claudio
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (02) : 181 - 182
  • [50] Cost-effectiveness analysis of different drug therapies for osteoporosis
    Dzajkovska, B
    VALUE IN HEALTH, 2003, 6 (06) : 730 - 730